Bisdemethoxycurcumin inhibits oxidative stress and antagonizes Alzheimer's disease by up‐regulating SIRT1
Brain and Behavior2020Vol. 10(7), pp. e01655–e01655
Citations Over TimeTop 10% of 2020 papers
Yan Xu, Rong Hu, Duanqun He, Guijuan Zhou, Heng Wu, Chenlin Xu, Bing He, Lin Wu, Yilin Wang, Yunqian Chang, Rundong Ma, Ming Xie, Zijian Xiao
Abstract
Our findings demonstrated that in the AD mice, BDMC has antagonistic effect on AD. And an intermediate step in the antagonism effect is caused by SIRT1 upregulation, which leading to decreased oxidative stress. Based on these, we concluded that BDMC injection into the lateral ventricle can act against AD by upregulating SIRT1 to antioxidative stress.
Related Papers
- → Curcumin and Curcumin-like Molecules: From Spice to Drugs(2013)188 cited
- → Analysis of the anticancer activity of curcuminoids, thiotryptophan and 4-phenoxyphenol derivatives(2013)24 cited
- Anti Oxidant Potential of “Cureit”- A Novel BioAvailable Curcumin Formulation(2014)
- → Metabolic Fate of Curcumin in the Gastrointestinal Tract in Mice(2016)1 cited
- → Evaluation of Curcumin Nanoparticles against Rabbit Skin Infection(2023)